Chargement en cours...

SUN-385 Differential Effects of Abaloparatide and Teriparatide on Hip Cortical Volumetric BMD by DXA-Based 3d Modeling

The osteoanabolic agent abaloparatide (ABL) has been shown to significantly increase total hip BMD over an 18-month period in postmenopausal women with osteoporosis. However, it remains unknown if these gains predominantly occur in the cortical or trabecular compartments of the proximal femur, and h...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Endocr Soc
Auteurs principaux: Winzenrieth, Renaud, Ominsky, Michael S, Wang, Yamei, Humbert, Ludovic, Weiss, Richard J
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7209294/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.255
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!